Abstract
BACKGROUND:Previous studies suggested that alterations in serum cortisol and DHEA-S levels may play a role in the pathophysiology of schizophrenia.AIM:To compare serum cortisol and DHEA-S levels between patients with schizophrenia and healthy controls and to evaluate their association with the response to antipsychotic treatment.MATERIAL AND METHODS:In this clinical prospective study were included 60 patients with schizophrenia and 40 healthy age and sex matched control subjects. Clinical evaluation of patients was performed using the Positive and Negative Symptom Scale. A questionnaire for socio-demographic and clinical data collection was used. For the purposes of the study, the examined group was divided in two subgroups: responders and nonresponders. Serum cortisol and DHEA-S levels were measured at baseline in all participants and after 3 and 6 weeks of the antipsychotic treatment in patients with schizophrenia.RESULTS:Patients with schizophrenia had significantly higher serum cortisol and DHEA-S levels in comparison to the control group. Responders had significantly higher serum cortisol and DHEA-S levels compared with nonresponders.CONCLUSION:Elevated serum cortisol and DHEA-S levels may play a role in the pathophysiology of schizophrenia and they may be related to positive response to antipsychotic treatment in patients with schizophrenia.
Highlights
The neuroendocrinologic system, the HPA axis, has been a focus of interest for neurobiological studies aiming at elucidating the cause of schizophrenia [1]
Serum cortisol and Dehydroepiandrosterone sulfate (DHEA-S) levels may be used as a biological marker for the diagnosis of schizophrenia; further studies with larger sample sizes are warranted to support this finding [2]
According to our results we can conclude that elevated serum cortisol and DHEA-S levels in patients with schizophrenia may play a role in the pathophysiology of schizophrenia and they may be used as a biological marker for the diagnosis of Across all three assessment points the responders had a significantly higher serum cortisol and DHEA-S levels compared with nonresponders
Summary
The neuroendocrinologic system, the HPA axis, has been a focus of interest for neurobiological studies aiming at elucidating the cause of schizophrenia [1]. There has been increased interest in the role of dehydroepiadrosterone (DHEA) which, in its sulfated form (DHEA-S) is the most abundant in humans [13]. It is considered both a neurosteroid, being produced in the brain, as well as a neuroactive steroid, produced in the adrenals and gonads and having its effect on the brain [14]. Previous studies suggested that alterations in serum cortisol and DHEA-S levels may play a role in the pathophysiology of schizophrenia
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
